Cubresa is launching its clinical product, the BrainPET, a PET insert designed for use in an MR scanner, enabling simultaneous PET/MRI imaging of the brain.
“We are in discussions with a number of notable research centers and are looking forward to finalizing our early customers this year,” said Lisa Bako, director of marketing for Cubresa.
The BrainPET scanner may play an important role in the diagnosis, treatment, and management of diseases of the brain including Alzheimer’s, epilepsy, brain cancer, and psychiatric disorders like addiction. The BrainPET is not yet FDA or Health Canada approved, and early customers will use the device for clinical research purposes.
In September 2020, Cubresa was awarded a contract by Innovative Solutions Canada for its recently launched NuPET Bio, the company’s preclinical PET scanner that is lightweight, portable and designed for use in infectious disease research within high containment facilities. A system has been installed at the IWK Health Center in Halifax and will be used for preclinical research into SARS-CoV-2 and other infectious diseases.
-Health Care Business News